RCHT contributes to UK study that confirms less intensive radiotherapy is safe and effective for early breast cancer

A landmark UK study has revealed that women aged 50+ with low-risk early breast cancer after breast-conserving surgery, can safely receive less intensive radiotherapy without compromising treatment effectiveness. The 10-year results, was led by Dr Duncan Wheatley, former Consultant Oncologist at the Royal Cornwall Hospital, offer new hope for thousands of patients seeking gentler treatment options.

Cornwall patients help shape national heart treatment decision

New national guidance could see over a million people in England offered semaglutide (Wegovy) to reduce their risk of heart attack and stroke.

RCHT team helps deliver world’s largest penicillin allergy study

Royal Cornwall Hospitals NHS Trust (RCHT) has played an important role in the world’s largest study into penicillin allergy. The international project, led by researchers in Melbourne, Australia, involved more than 5,000 patients across 40 hospitals in eight countries and has shown that most people who believe they are allergic to penicillin are not actually allergic.

Research participant Rod Richardson head and shoulders photo

Life-changing research at RCHT helps local man to beat cancer and return to an active, adventurous life

Royal Cornwall Hospitals NHS Trust (RCHT) is celebrating the remarkable recovery of Rod Richardson, a 77‑year‑old grandfather from St Austell, whose life has been transformed thanks to cutting-edge haematology research.

Research participant Jackie and doctor Madalina stand together in clinic room

14 years of research: one patient’s continuing commitment to clinical trials at RCHT

For 14 years, Jackie Eastwood has been an unwavering supporter of clinical research at the Royal Cornwall Hospitals NHS Trust (RCHT). At 57, and while working as Volunteer Manager for Cornwall Air Ambulance, she has dedicated her time to contributing to studies that improve treatment and outcomes for people with breast cancer.

Clinical Fellow Joe with blue sky and mountains in the background

Supporting sepsis research: API scheme success on the SHORTER trial at RCHT

Clinical Fellow, Dr Joe Parker, has successfully completed the NIHR Associate Principal Investigator (API) Scheme for the SHORTER Study at the Royal Cornwall Hospitals NHS Trust (RCHT). The trial, taking place in the Critical Care Unit (CCU), is comparing different durations of antibiotic treatment for sepsis.

man completing survey on his phone

Royal Cornwall Hospitals NHS Trust achieves highest PRES returns in the South West

Royal Cornwall Hospitals NHS Trust (RCHT) is proud to announce that it received the highest number of responses in the South West for the Participant in Research Experience Survey (PRES) during 2024/25, with an impressive 279 returns. This achievement reflects our commitment to listening to research participants and continuously improving the experience of those who take part in health and care studies. 

Dr Priya Joshi

Royal Cornwall Hospitals NHS Trust sponsors innovative study on the 1939 Cancer Act in the digital age 

Royal Cornwall Hospitals NHS Trust (RCHT) is proud to sponsor a pioneering research project that will examine the relevance and effectiveness of the 1939 Cancer Act in today’s digital era.

Alan rings the bell to mark the end of his treatment

Blood cancer research making a difference in Cornwall

This September, during Blood Cancer Awareness Month, the Royal Cornwall Hospitals NHS Trust (RCHT) is proud to share the uplifting story of 66-year-old Alan Gooden. Alan, a recently retired building services design engineer from Mylor Bridge, is grateful to have had the opportunity to participate in a pioneering research trial. He feels that his experience in research, has not only allowed him to be more closely monitored but could also help shape future treatments for others.

Patient and doctor consultation.

Royal Cornwall Hospitals NHS Trust contributes to trial showing hope in extending survival for prostate cancer patients

A major international clinical trial has published findings showing that a new combination of drugs can significantly extend the lives of men with advanced prostate cancer. The TALAPRO-2 trial, which included patients from Royal Cornwall Hospitals NHS Trust (RCHT), tested a treatment that could become a new standard of care.

Text Size

Change font

Contrast